Lori Koch
Director of Finance/CFO presso DUPONT DE NEMOURS, INC.
Patrimonio netto: 8 M $ in data 31/03/2024
Profilo
Attualmente, Lori D. Koch occupa la posizione di Chief Financial Officer & Executive Vice President presso DuPont de Nemours, Inc. e di Director, Chief Financial Officer & Executive VP presso Nutrition & Biosciences, Inc. (una consociata di DuPont de Nemours, Inc.). La signora Koch è anche nel consiglio di amministrazione di Aceto Corp. La signora Koch ha conseguito una laurea e un diploma di laurea presso il Babson College e una laurea presso la Pennsylvania State University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
DUPONT DE NEMOURS, INC.
0.02% | 02/03/2024 | 100 219 ( 0.02% ) | 8 M $ | 31/03/2024 |
Posizioni attive di Lori Koch
Società | Posizione | Inizio |
---|---|---|
DUPONT DE NEMOURS, INC. | Director of Finance/CFO | 17/02/2020 |
ACETO CORPORATION | Director/Board Member | 01/12/2019 |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Director of Finance/CFO | - |
Precedenti posizioni note di Lori Koch
Società | Posizione | Fine |
---|---|---|
E I DU PONT DE NEMOURS AND CO | Director of Finance/CFO | - |
Formazione di Lori Koch
Babson College | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
DUPONT DE NEMOURS, INC. | Process Industries |
Aziende private | 3 |
---|---|
Actylis Corp.
Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Process Industries |
- Borsa valori
- Insiders
- Lori Koch